| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |